Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

CNBC Halftime Report Final Trades: Bristol-Myers Squibb, Salesforce & Cheniere Energy

– CNBC

byBenzinga Newsdesk

September 22, 2022

1 minute read

– CNBC

ShiftPixy Secures Exclusive Distribution Rights For Genesis One Anti-Virus Laser Systems

By Akanksha

Today, 8:28 AM

ShiftPixy Inc (NASDAQ:PIXY) announced an agreement in principle with Quelliv, Inc., an exclusive manufacturer, and distributor of the anti-viral biotechnology Genesis One laser…

PIXY

FDA
News

J&J’s Janssen Presents Updated Data At European Hematology Association For Teclistamab In Patients With Relapsed Or Refractory Multiple Myeloma

By Benzinga Newsdesk

Today, 8:28 AM

-Reuters

JNJ

Elon Musk Confirmed in a Tweet Monday Hertz Paying Same Price as Consumers for Tesla Cars

By Charles Gross

Today, 8:28 AM

https://twitter.com/elonmusk/status/1452794619410927625?s=20

TSLA

Applied Molecular Q3 EPS $(0.68) Down From $(0.48) YoY

By Benzinga Newsdesk

Today, 8:28 AM

Applied Molecular (NASDAQ:AMTI) reported quarterly losses of $(0.68) per share. This is a 41.67 percent decrease over losses of $(0.48) per share from the same period last year.

AMTI

CNBC Halftime Report Final Trades: Bristol-Myers Squibb, Salesforce & Cheniere Energy

Related Posts

ShiftPixy Secures Exclusive Distribution Rights For Genesis One Anti-Virus Laser Systems

J&J’s Janssen Presents Updated Data At European Hematology Association For Teclistamab In Patients With Relapsed Or Refractory Multiple Myeloma

Elon Musk Confirmed in a Tweet Monday Hertz Paying Same Price as Consumers for Tesla Cars

Applied Molecular Q3 EPS $(0.68) Down From $(0.48) YoY